Hernan Levett
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Hernan Levett is currently Director at Versameb AG and Chief Financial Officer at BioVersys AG, both positions started in 2023.
Former roles include Chief Financial Officer at Spexis Ltd. from 2019 to 2023, Head-Group Controlling at Acino Pharma AG, Chief Financial Officer at Novartis Chile SA, Vice President-Finance at InterMune International AG, and Chief Financial & Accounting Officer at Altamira Therapeutics Ltd. from 2017 to 2019.
Education includes an undergraduate degree from Universidad de Buenos Aires.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOVERSYS AG -.--% | 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOVERSYS AG | Directeur Financier/CFO | 01/11/2023 |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Directeur/Membre du Conseil | 11/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| SPEXIS AG | Directeur Financier/CFO | 01/12/2023 |
| ALTAMIRA THERAPEUTICS LTD. | Directeur Financier/CFO | 31/10/2019 |
Novartis Chile SA | Directeur Financier/CFO | - |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Directeur Financier/CFO | - |
Acino Pharma AG
Acino Pharma AG Pharmaceuticals: MajorHealth Technology Develops and manufactures oral modified release pharmaceuticals, trans dermal patches and biodegradable implants | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Acino Pharma AG
Acino Pharma AG Pharmaceuticals: MajorHealth Technology Develops and manufactures oral modified release pharmaceuticals, trans dermal patches and biodegradable implants | Health Technology |
Novartis Chile SA | |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
BioVersys AG
BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national